SEC Filing · 4
Crinetics Pharmaceuticals, Inc.
SEC Filing
Company context
Crinetics Pharmaceuticals is a global pharmaceutical company committed to transforming the treatment of endocrine diseases through science rooted in patient needs. Crinetics is focused on discovering, developing, and commercializing novel therapies, with core expertise in targeting G-protein coupled receptors (GPCRs) with small molecules that have specifically tailored pharmacology and properties.
Historical securities (1)
Document unavailable
This filing is not currently available in the archive. Read it on SEC EDGAR ↗